Evaluation of CD25+CD4+ Regulatory T-Lymphocyte Subpopulations in Coronary Artery Diseases Patients

Table 2

T-lymphocyte subpopulations in patients with stable and unstable coronary diseases.

	Group 1	Group 2	𝑃  value
Leukocytes; (G/L)	7,12 ± 1,7	6,8 ± 2,7	NS
Lymphocytes; (G/L)	2,76 ± 0,29	2,63 ± 0,48	NS
T-lymphocytes (G/L)	1,68 ± 0,42	1,69 ± 0,38	NS
B-lymphocytes (G/L)	0,26 ± 0,06	0,33 ± 0,08	NS
Natural killers; (G/L)	0,36 ± 0,1	0,32 ± 0,09	NS
T-helperlymphocytes; (G/L)	1,16 ± 0,4	1,00 ± 03	NS
T-suppressor lymphocytes; (G/L)	0,7 ± 0,06	0,8 ± 0,07	NS
Activated; T-lymphocytes; (G/L)	0,23 ± 0,08	0,28 ± 0,02	<0,05